Health1 year ago
Dr Ricciuti on PD-L1 Expression and Long-Term Survival Outcomes With PD-L1 Inhibitors in Advanced NSCLC
Biagio Ricciuti, MD, thoracic medical oncologist, staff scientist II, Department of Medicine, Dana-Farber Cancer Institute, discusses the association between PD-L1 expression levels and long-term survival with anti–PD-L1...
Recent Comments